Additionally, VE-Cadherin and FGFR1 levels were reduced in DCKO tumors compared to control tumors, reflective of reduced tumor angiogenesis and tumor endothelial Fgfr1 deletion (Supplementary Fig. S2A). This evidence concerns the gene FGFR1 and neoplasm.